ÃØÃÜÑо¿Ëù

Internal Server Error
Unlock full details of this profile with our freeÌýLiteÌý±è±ô²¹²Ô!
Signup and get free access

Last updated:

About Omega Funds

Omega Funds is a venture capital firm founded in 2004. It is primarily based out of Boston, United States. As of Dec 2024, Omega Funds is an active investor, having invested in 133 companies, with 7 new investments in the last 12 months. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it led the $208M Series C round of Aviceda Therapeutics along with Orbimed. This round also saw participation from Marshall Wace and other investors.
Overall, Omega Funds portfolio has seen 1 unicorn, 47 IPOs and 43 acquisitions including key companies like BridgeBio, Evotec and Immunocore. A lot of funds co-invest with Omega Funds, with names like EcoR1 sharing a substantial percentage of its portfolio.
Omega Funds has team of 26 people including 13 partners.
Key Metrics
Team Members
, &
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B &
Portfolio IPOs
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
Deals in last 12 months
Get Omega Funds' portfolio delivered to your inbox!

Omega Funds' Investment Trends by Stage

Omega Funds has made 27 investments in Series A stage with an average round size of $73.2M, 25 investments in Series B stage with an average round size of $81M and 14 investments in Series C stage with an average round size of $96.5M.
Here are Omega Funds' investment trends by stages:
Note: We have considered here, only first round of investments
Breakdown of Omega Funds' investments by stage of entrySeries A (27)Series B (25)
Stage of entry
No. of Investments
Series A
27
Series B
25
Series C
14
Post IPO
7
Series D
4
Others
3

Omega Funds' Investment Trends by Sector

Omega Funds has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Sustainability Tech, Healthcare and Artificial Intelligence - Industry Applications. Notably, it has invested in 112 Tech companies, 110 Enterprise (B2B) companies, 11 Tech hardware companies and at least 5 companies focusing on Software.
Here are Omega Funds' investment trends by sector:
Note: We have considered here, only first round of investments
Breakdown of Omega Funds' investments by sectorsLife Sciences (77)High Tech (17)
Sector
No. of Investments
Life Sciences
77
High Tech
17
Sustainability Tech
8
Healthcare
4
Artificial Intelligence - Industry Applications
2
Others
6

Omega Funds' Investment Trends by Geography

Omega Funds has made most investments in United States (80), followed by United Kingdom where it has made 11 investments.
Here are Omega Funds' investment trends by geography:
Note: We have considered here, only first round of investments
Breakdown of Omega Funds' investments by countriesUnited States (57)Switzerland (7)
Country
No. of Investments
United States
57
Switzerland
7
United Kingdom
6
Canada
2
France
2
Others
7

Omega Funds' recent investments

Omega Funds has not made any investment in 2025 so far.
Here are the most recent investments by Omega Funds:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Dec 19, 2024
United States
Series C
$90.8M
Dec 17, 2024
United States
Series C
$208M
Nov 13, 2024
United States
Series E
$60M
[+6]
Aug 20, 2024
United States
Series B
$45M
[+5]
Jul 24, 2024
United States
Series B
$196M
[+7]
lockGet the detailed list of all investments by Omega Funds. Download now!

Unicorns in Omega Funds' Portfolio

Omega Funds has 1 unicorns in its portfolio - Intarcia.ÌýThe most recent unicorn in their portfolio is Intarcia which became a unicorn in 2014, -11 years after Omega Funds first invested in it.
Here is a list of unicorns in Omega Funds' portfolio:
ÃØÃÜÑо¿Ëù Score
Company
Short Description
Founded year
Sector
Location
Company Stage
First Investment/ Acquisition Details
33
Provider of osmotic pump for subcutaneous drug delivery
1995
Boston
Series J
evnzjiq

IPOs and Publicly Listed companies in Omega Funds' Portfolio

47 of Omega Funds' portfolio companies have become public.ÌýKestra Medical Technologies got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Mar 2025 at marketcap of $842MÌýand Beta Bionics got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $695M.
Here are Omega Funds' portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Mar 06, 2025
Jul 24, 2024
Series B
$196M
Jan 30, 2025
Aug 28, 2023
Series D
$100M
Oct 11, 2024
Jun 02, 2022
Series A
$200M
Sep 13, 2024
Mar 06, 2023
Series B
$108M
Jun 28, 2024
Mar 07, 2024
Series C
$259M

Acquired companies in Omega Funds' Portfolio

43 companies from Omega Funds' portfolio have been acquired.ÌýThe most recent acquisition were SoniVie in Mar 2025Ìýby Boston Scientific for $360M.
Here are Omega Funds' portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Mar 03, 2025
Jan 09, 2023
Series C
$60M
Jul 25, 2024
Jul 19, 2013
Series C
$73.4M
Jul 08, 2024
Jun 30, 2016
Series A
$51.5M
May 30, 2024
Nov 14, 2023
Series A
$65M
Apr 10, 2024
Jul 24, 2020
Post IPO
$60M

Team profile of Omega Funds

Omega Funds has a team of 26 membersÌýincluding 13 Partners, 3 Venture Partners and 3 PrincipalsÌýlocated in United States, Switzerland and . Omega Funds' team does not sit on the board of any company as of now.
Here is a list of top team members in Omega Funds:
Name
Designation
Location
Board Memberships
Contact details
Partner
Boston
-
Partner
Geneva
-
Partner
Geneva
-
Partner
Boston
-
Partner
United States
-
Partner
Lexington
-
-
Partner
Switzerland
-
Partner
Toronto
-
Partner
Boston
-
Partner
Cambridge
-
-
Partner
Cambridge
-
lockGet the full list of Omega Funds' team & partners for free. Download now!

Co-investors of Omega Funds

Over the past 19 years, 552 investors have co-invested in Omega Funds's portfolio companies.

  • Invested before Omega Funds:ÌýHHS, Atlas Venture and 191 others have invested in rounds before Omega Funds. There are 7 companies where HHS has invested before Omega Funds and 6 companies where Atlas Venture has invested before Omega Funds.
  • Top Co-investors of Omega Funds:Ìý209 investors entered a company along with Omega Funds. These include investors like EcoR1 (8 companies).
  • Invested after Omega Funds:ÌýA total of 150 investors have invested in Omega Funds's portfolio after their investments. Top Investors include Alexandria (5 companies), Bain Capital Life Sciences (4 companies) and Invus (4 companies).
Get full list of Omega Funds' co-investors delivered to your inbox!

Recent News related to Omega Funds

•
intelligence360•Mar 17, 2025•, Frazier Life Sciences, Jeito, Novo Holdings and 7 others
•
Pharmaceutical Technology•Mar 04, 2025•, Frazier Life Sciences, Jeito, Omega Funds and 3 others
•
Jinglingshuju•Mar 04, 2025•, Frazier Life Sciences, Jeito, Novo Holdings and 6 others
•
BioPharmaDive•Mar 03, 2025•Hummingbird Bioscience, Frazier Healthcare Partners, Jeito, Novo Holdings and 9 others
•
CNW•Mar 03, 2025•, Frazier Life Sciences, Jeito, Novo Holdings and 10 others
•
GlobeNewswire•Mar 03, 2025•Jeito, , Hummingbird Bioscience, Frazier Life Sciences and 8 others
•
intelligence360•Jan 17, 2025•Aviceda Therapeutics, Omega Funds, TCG Crossover, Enavate Sciences and 3 others
•
Business Wire•Jan 14, 2025•Alleviant Medical, Gilde Healthcare, S3 Ventures, RiverVest Venture Partners and 7 others
•
FinSMEs•Jan 13, 2025•, Pivotal Life Sciences, Quan Capital, Qiming Venture Partners and 8 others
•
Business Wire•Jan 07, 2025•Aviceda Therapeutics, Omega Funds, TCG Crossover, Enavate Sciences and 9 others
Unlock full details of this profile with our freeÌýLiteÌý±è±ô²¹²Ô!Signup and get free accessÌýarrow-right-long